Cargando…

Improved prognosis for recurrent epithelial ovarian cancer by early diagnosis and 125I seeds implantation during suboptimal secondary cytoreductive surgery: a case report and literature review

BACKGROUND: Epithelial ovarian cancer (EOC) has the worst prognosis in all of gynecologic malignant tumors because of its high recurrence and eventually chemo-resistance. Early diagnosis of recurrence is crucial to avoid diffuse dissemination. Failure of traditional treatment in recurrent epithelial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Lin, Tang, Junying, Li, Wenbo, Xu, Xuexun, Zhang, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702710/ https://www.ncbi.nlm.nih.gov/pubmed/33250044 http://dx.doi.org/10.1186/s13048-020-00744-2

Ejemplares similares

Efficacy and prognosis of surgery combined with (125)I seed implantation in treatment of recurrent glioma
por: Li, Weichang, et al.
Publicado: (2017)

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
por: Onda, T, et al.
Publicado: (2005)

Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
por: Winarno, G. N. A., et al.
Publicado: (2020)

Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
por: Certelli, Camilla, et al.
Publicado: (2023)

Preoperative Lymphocyte-Monocyte Ratio Is a Predictor of Suboptimal Cytoreduction in Stage III-IV Epithelial Ovarian Cancer
por: Eo, Wankyu, et al.
Publicado: (2016)

Validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer
por: Llueca, Antoni, et al.
Publicado: (2021)

The current role of secondary cytoreductive surgery for recurrent ovarian cancer
por: de Bree, Eelco, et al.
Publicado: (2022)

Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2016)

Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer
por: Son, Joo-Hyuk, et al.
Publicado: (2022)

Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
por: Bogani, Giorgio, et al.
Publicado: (2018)

Minilaparotomy, Cyfra21-1, and Other Predicting Factors for Suboptimal Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer: A Pilot Study
por: Nantasupha, Chalaithorn, et al.
Publicado: (2022)

Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
por: Zang, Rongyu, et al.
Publicado: (2019)

Predictive significance of preoperative CT findings for suboptimal cytoreduction in advanced ovarian cancer: a meta-analysis
por: Hu, Ting Wen Yi, et al.
Publicado: (2018)

Preoperative Serum CA-125 Level As a Predictor for The Extent of Cytoreduction in Patients with Advanced Stage Epithelial Ovarian Cancer
por: Merlo, Sebastjan, et al.
Publicado: (2021)

Giant calcifying epithelial odontogenic tumor after I-125 seed implantation: A case report
por: Li, Yanchen, et al.
Publicado: (2023)

(125)I Radioactive Seeds Implantation Therapy for Hepatocellular Carcinoma
por: Lv, Jin, et al.
Publicado: (2009)

Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review
por: Conte, Carmine, et al.
Publicado: (2021)

Prediction Models for Complete Resection in Secondary Cytoreductive Surgery of Patients With Recurrent Ovarian Cancer
por: Jiang, Caixia, et al.
Publicado: (2021)

Clinical application of CT-guided (125)I seed interstitial implantation for local recurrent rectal carcinoma
por: Wang, Zhongmin, et al.
Publicado: (2011)

CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery
por: Wang, Fang, et al.
Publicado: (2013)

The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer
por: Yang, Zhi-jun, et al.
Publicado: (2016)

Splenectomy during cytoreductive surgery in epithelial ovarian cancer
por: Sun, Hengzi, et al.
Publicado: (2018)

Radiation-related Adverse Effects of CT-guided Implantation of (125)I Seeds for Thoracic Recurrent and/or Metastatic Malignancy
por: Ji, Zhe, et al.
Publicado: (2019)

Re-implantation of suboptimal prostate seed implantation: technique with intraoperative treatment planning
por: Doyle, Laura, et al.
Publicado: (2012)

A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
por: Bogani, Giorgio, et al.
Publicado: (2018)

Tertiary cytoreduction in the setting of recurrent ovarian cancer (Review)
por: DOGAN, NASUH UTKU, et al.
Publicado: (2013)

CT-guided (125)I brachytherapy for recurrent ovarian cancer
por: Liu, Ping, et al.
Publicado: (2017)

Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer
por: Jiang, Qin, et al.
Publicado: (2021)

Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index
por: Llueca, Antoni, et al.
Publicado: (2018)

An investigation of (125)I seed permanent implantation for recurrent carcinoma in the head and neck after surgery and external beam radiotherapy
por: Zhu, Lihong, et al.
Publicado: (2013)

Computed tomography-guided implantation of (125)I seeds brachytherapy for recurrent multiple pulmonary oligometastases: initial experience and results
por: Li, Jie, et al.
Publicado: (2017)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019)

The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us?
por: Coleman, Robert L.
Publicado: (2020)

MR‐guided 125I seed implantation treatment for maxillofacial malignant tumor
por: Wang, Ying, et al.
Publicado: (2020)

CT-guided iodine-125 seed permanent implantation for recurrent head and neck cancers
por: Jiang, Yu L, et al.
Publicado: (2010)

Chinese Expert Consensus on Iodine(125) Seed Implantation for Recurrent Cervical Cancer in 2021
por: Jiang, Ping, et al.
Publicado: (2021)

Nomogram to predict postoperative complications after cytoreductive surgery for advanced epithelial ovarian cancer: A multicenter retrospective cohort study
por: Jiang, Caixia, et al.
Publicado: (2022)

Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
por: Saffarieh, Elham, et al.
Publicado: (2022)

Retraction Note: The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer
por: Yang, Zhi-jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uqeu0s07dh28lafhrnj3a7ckob